Jodrellin A
| Code | Size | Price |
|---|
| TAR-T32309-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Jodrellin A is a bioactive chemical.
CAS:
124901-80-0
Formula:
C24H32O8
Molecular Weight:
448.512
Purity:
0.98
SMILES:
C[C@@H]1C[C@H](OC(C)=O)[C@@]23C[C@@]4(CO4)[C@H](C[C@H]2[C@]1(C)[C@@H]1C[C@H]2C=CO[C@@H]2O1)O[C@@H]3OC(C)=O
References
1. Koh SB, Wallez Y, Dunlop CR, Bernaldo de Quir?s Fern?ndez S, Bapiro TE, Richards FM, Jodrell DI. Mechanistic distinctions between CHK1 and WEE1 inhibition guide the scheduling of triple therapy with gemcitabine. Cancer Res. 2018 May 7. pii: canres.3932.2017. doi: 10.1158/0008-5472.CAN-17-3932. [Epub ahead of print] PubMed PMID: 29735549.
2. Candido JB, Morton JP, Bailey P, Campbell AD, Karim SA, Jamieson T, Lapienyte L, Gopinathan A, Clark W, McGhee EJ, Wang J, Escorcio-Correia M, Zollinger R, Roshani R, Drew L, Rishi L, Arkell R, Evans TRJ, Nixon C, Jodrell DI, Wilkinson RW, Biankin AV, Barry ST, Balkwill FR, Sansom OJ. CSF1R(+) Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype. Cell Rep. 2018 May 1;23(5):1448-1460. doi: 10.1016/j.celrep.2018.03.131. PubMed PMID: 29719257; PubMed Central PMCID: PMC5946718.
3. Fornari C, O'Connor LO, Yates JWT, Cheung SYA, Jodrell DI, Mettetal JT, Collins TA. Understanding Hematological Toxicities Using Mathematical Modeling. Clin Pharmacol Ther. 2018 Mar 31. doi: 10.1002/cpt.1080. [Epub ahead of print] Review. PubMed PMID: 29604045.
4. Sng CCT, O'Byrne S, Prigozhin DM, Bauer MR, Harvey JC, Ruhle M, Challis BG, Lear S, Roberts LD, Workman S, Janowitz T, Magiera L, Doffinger R, Buckland MS, Jodrell DJ, Semple RK, Wilson TJ, Modis Y, Thaventhiran JED. A type III complement factor D deficiency: Structural insights for inhibition of the alternative pathway. J Allergy Clin Immunol. 2018 Mar 6. pii: S0091-6749(18)30327-0. doi: 10.1016/j.jaci.2018.01.048. [Epub ahead of print] PubMed PMID: 29522842.